The relationship between RAGE gene four common polymorphisms and breast cancer risk in northeastern Han Chinese

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Pan, Hongming ^a   He, Lan ^a   Wang, Bin ^a   Niu, Wenquan ^b  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

AGED; ALLELE; ARTICLE; ASIAN; BREAST TUMOR; CASE CONTROL STUDY; EPISTASIS; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; MIDDLE AGED; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RISK FACTORS;

EID: 84896291628     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04355     Document Type: Article

References (31)

1. Warren Andersen, S. et al. The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk. Breast Cancer Res Treat 140, 427-434 (2013).
2. Niu, W., Qi, Y., Gao, P. & Zhu, D. Association of TGFB1 -509 C . T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects. Breast Cancer Res Treat 124, 243-249 (2010).
3. Sapkota, Y. et al. Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One 8, e64896 (2013).
4. Oestergaard, M. Z. et al. Interactions between genes involved in the antioxidant defence system and breast cancer risk. British journal of cancer 95, 525-531 (2006). (Pubitemid 44232563)
5. Phillips, P. C. Epistasis-the essential role of gene interactions in the structure and evolution of genetic systems. Nat Rev Genet 9, 855-867 (2008).
6. Moore, J. H. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 4, 795-803 (2004). (Pubitemid 39487584)
7. Gui, J. et al. A Simple and Computationally Efficient Approach to Multifactor Dimensionality Reduction Analysis of Gene-Gene Interactions for Quantitative Traits. PLoS One 8, e66545 (2013).
8. Guo, S. et al. Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese. PLoS One 7, e39814 (2012).
9. Guo, S. et al. The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese. PLoS One 8, e56213 (2013).
10. Pan, H. et al. Contributory role of five common polymorphisms of RAGE and APE1 genes in lung cancer among Han Chinese. PLoS One 8, e69018 (2013).
11. Tesarova, P. et al. Receptor for advanced glycation end products (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest 25, 720-725 (2007). (Pubitemid 350223177)
12. Jing, R., Cui, M., Wang, J. & Wang, H. Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer. Neoplasma 57, 55-61 (2010).
13. Ishiguro, H. et al. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. The Prostate 64, 92-100 (2005). (Pubitemid 40734743)
14. Jiao, L. et al. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 20, 1430-1438 (2011).
15. Zhang, S. et al. Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 31, 525-531 (2013).
16. Taguchi, A. et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405, 354-360 (2000). (Pubitemid 30337069)
17. Catalano, M. et al. The Pro12Ala polymorphism of peroxisome proliferatoractivated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease. Clinical biochemistry 41, 981-985 (2008).
18. Ng, Z. X., Kuppusamy, U. R., Iqbal, T. & Chua, K. H. Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy. Gene 521, 227-233 (2013).
19. Cheng, D. T. et al. Systemic sRAGE is a Biomarker of Emphysema and Associated with AGER Genetic Variants in COPD Patients. Am J Respir Crit Care Med (2013).
20. Niu, W. et al. A meta-analysis of receptor for advanced glycation end products gene: four well-evaluated polymorphisms with diabetes mellitus. Molecular and cellular endocrinology 358, 9-17 (2012).
21. Forbes, J. M. et al. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia 54, 1032-1042 (2011).
22. Khanna, M. et al.Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors. Oncogene 18, 27-38 (1999). (Pubitemid 29060576)
23. Neeper, M. et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. The Journal of biological chemistry 267, 14998-15004 (1992).
24. Stram, D. O. et al. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 55, 179-190 (2003). (Pubitemid 37323455)
25. Pattin, K. A. et al. A computationally efficient hypothesis testing method for epistasis analysis usingmultifactor dimensionality reduction. Genet Epidemiol 33, 87-94 (2009).
26. Hahn, L.W., Ritchie, M. D. & Moore, J. H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19, 376-382 (2003). (Pubitemid 36284937)
27. Hashemi, M. et al. Genotyping of -374A/T, -429A/G, and 63 bp Ins/del polymorphisms of RAGE by rapid one-step hexaprimer amplification refractory mutation system polymerase chain reaction in breast cancer patients. Nucleosides, nucleotides & nucleic acids 31, 401-410 (2012).
28. Ribas, G., Milne, R. L., Gonzalez-Neira, A. & Benitez, J. Haplotype patterns in cancer-related genes with long-range linkage disequilibrium: no evidence of association with breast cancer or positive selection. Eur J Hum Genet 16, 252-260 (2008).
29. Gu, M. et al. Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis. PLoS One 7, e37970 (2012).
30. Fishchuk, L. E. & Gorovenko, N. G. Genetic polymorphisms of the reninangiotensin system in breast cancer patients. Exp Oncol 35, 101-104 (2013).
31. Xi, B. et al. Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 130, 561-568 (2011).